Myeloma-derived MIP1α increases RANKL expression in osteocytes and contributes to bone destruction and tumor growth

被引:0
|
作者
Anloague, Aric [1 ]
Sabol, Hayley M. [1 ]
Kaur, Japneet [2 ]
Adhikari, Manish [1 ]
Khan, Sharmin [1 ]
Ashby, Cody [2 ]
Roodman, G. David [3 ]
Barnes, C. Lowry [4 ]
Ambrogini, Elena [5 ]
Bellido, Teresita M. [1 ]
Delgado-Calle, Jesus [2 ]
机构
[1] Univ Arkansas Med Sci, Dept Physiol & Cell Biol, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA
[3] Indiana Univ Sch Med, Hematol Oncol, Med, Indianapolis, IN 46202 USA
[4] Univ Arkansas Med Sci, Dept Orthoped Surg, Little Rock, AR 72205 USA
[5] Univ Arkansas Med Sci, Div Endocrinol & Metab, Little Rock, AR 72205 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI-246
引用
收藏
页码:37 / 37
页数:1
相关论文
共 14 条
  • [1] Multiple Myeloma-Derived MIP-1α Regulates Osteocytic RANKL Expression Via Autocrine HMGB1 Signaling In Osteocytes
    Anloague, Aric
    Khan, Sharmin
    Roodman, G. David
    Bellido, Teresita
    Delgado-Calle, Jesus
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 244 - 244
  • [2] MIP1 produced by myeloma cells enhances bone destruction, myeloma cell survival, and suppresses dendritic cell formation
    Matsumoto, T
    Abe, M
    CANCER TREATMENT REVIEWS, 2005, 31 : S14 - S14
  • [3] Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction
    Sabol, Hayley M.
    Amorim, Tania
    Ashby, Cody
    Halladay, David
    Anderson, Judith
    Cregor, Meloney
    Sweet, Megan
    Nookaew, Intawat
    Kurihara, Noriyoshi
    Roodman, G. David
    Bellido, Teresita
    Delgado-Calle, Jesus
    NEOPLASIA, 2022, 28
  • [4] Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction
    Sabol, Hayley M.
    Amorim, Tania
    Ashby, Cody
    Halladay, David
    Anderson, Judith
    Cregor, Meloney
    Sweet, Megan
    Nookaew, Intawat
    Kurihara, Noriyoshi
    Roodman, G. David
    Bellido, Teresita
    Delgado-Calle, Jesus
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
    Colombo, Michela
    Galletti, Serena
    Bulfamante, Gaetano
    Falleni, Monica
    Tosi, Delfina
    Todoerti, Katia
    Lazzari, Elisa
    Crews, Leslie A.
    Jamieson, Catriona H. M.
    Ravaioli, Sara
    Baccianti, Francesco
    Garavelli, Silvia
    Platonova, Natalia
    Neri, Antonino
    Chiaramonte, Raffaella
    ONCOTARGET, 2016, 7 (35) : 56013 - 56029
  • [6] High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity
    Seidel, C
    Borset, M
    Hjertner, O
    Cao, DJ
    Abildgaard, N
    Hjorth-Hansen, H
    Sanderson, RD
    Waage, A
    Sundan, A
    BLOOD, 2000, 96 (09) : 3139 - 3146
  • [7] Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
    Qiang, Ya-Wei
    Chen, Yu
    Stephens, Owen
    Brown, Nathan
    Chen, Bangzheng
    Epstein, Joshua
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2008, 112 (01) : 196 - 207
  • [8] THERAPEUTIC IMPACT OF TAK-1 INHIBITION ON TUMOR GROWTH AND BONE DESTRUCTION IN MYELOMA
    Teramachi, J.
    Hiasa, M.
    Oda, A.
    Tenshin, H.
    Amachi, R.
    Harada, T.
    Nakamura, S.
    Miki, H.
    Endo, I.
    Haneji, T.
    Matsumoto, T.
    Abe, M.
    HAEMATOLOGICA, 2016, 101 : 162 - 162
  • [9] TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma tumor growth and bone destruction.
    Teramachi, Jumpei
    Hiasa, Masahiro
    Oda, Asuka
    Tenshin, Hirofumi
    Amachi, Ryota
    Harada, Takeshi
    Nakamura, Shingen
    Miki, Hirokazu
    Endo, Itsuro
    Haneji, Tatsuji
    Matsumoto, Toshio
    Abe, Masahiro
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S65 - S65
  • [10] Osterix inhibits RANKL and IL-1α in osteosarcoma cells resulting in decreased bone destruction and tumor growth.
    Cao, Y
    Zhou, Z
    Kleinerman, ES
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S359 - S359